Review Article
Pharmacogenetic Approach for the Prevention of Rivaroxaban’s ADRs: A Systematic Review and Meta-Analysis
Table 4
Genetic mutations in odds of rivaroxaban ADRs (bleeding following rivaroxaban administration).
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADR, adverse drug reaction; OR, odds ratio; CI, confidence interval; value was reported for the heterogeneity chi-squared test. A fixed model was used whenever value was less than 0.1. |